Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study.
Amoretti S, Mezquida G, Verdolini N, Bioque M, Sánchez-Torres AM, Pina-Camacho L, Zorrilla I, Trabsa A, Rodriguez-Jimenez R, Corripio I, Sarró S, Ibañez A, Usall J, Segarra R, Vieta E, Roberto N, Ramos-Quiroga JA, Tortorella A, Menculini G, Cuesta MJ, Parellada M, González-Pinto A, Berrocoso E, Bernardo M; 2EPs Group; Annex. Members of the 2EPs group. Amoretti S, et al. Among authors: segarra r. Span J Psychiatry Ment Health. 2023 Sep 14:S2950-2853(23)00010-8. doi: 10.1016/j.sjpmh.2023.04.001. Online ahead of print. Span J Psychiatry Ment Health. 2023. PMID: 38591832 Free article.
The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
Mezquida G, Cabrera B, Bioque M, Amoretti S, Lobo A, González-Pinto A, Espliego A, Corripio I, Vieta E, Castro-Fornieles J, Bergé D, Escartí MJ, Ibañez Á, Penadés R, Sánchez-Torres AM, Bernardo M; PEPs Group. Mezquida G, et al. Schizophr Res. 2017 Nov;189:84-90. doi: 10.1016/j.schres.2017.01.047. Epub 2017 Feb 6. Schizophr Res. 2017. PMID: 28185786
Individual trajectories of cognitive performance in first episode psychosis: a 2-year follow-up study.
Sánchez-Torres AM, Moreno-Izco L, Lorente-Omeñaca R, Cabrera B, Lobo A, González-Pinto AM, Merchán-Naranjo J, Corripio I, Vieta E, de la Serna E, Butjosa A, Contreras F, Sarró S, Mezquida G, Ribeiro M, Bernardo M, Cuesta MJ; PEPs group. Sánchez-Torres AM, et al. Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):699-711. doi: 10.1007/s00406-017-0857-z. Epub 2017 Nov 21. Eur Arch Psychiatry Clin Neurosci. 2018. PMID: 29164332
Smoking does not impact social and non-social cognition in patients with first episode psychosis.
Sánchez-Gutiérrez T, García-Portilla MP, Parellada M, Bobes J, Calvo A, Moreno-Izco L, González-Pinto A, Lobo A, de la Serna E, Cabrera B, Torrent C, Roldán L, Sanjuan J, Ibáñez Á, Sánchez-Torres AM, Corripio I, Bernardo M, Cuesta MJ; PEPs group. Sánchez-Gutiérrez T, et al. Schizophr Res. 2018 Sep;199:64-74. doi: 10.1016/j.schres.2018.03.025. Epub 2018 Mar 30. Schizophr Res. 2018. PMID: 29606546
Cognitive reserve as an outcome predictor: first-episode affective versus non-affective psychosis.
Amoretti S, Cabrera B, Torrent C, Mezquida G, Lobo A, González-Pinto A, Parellada M, Corripio I, Vieta E, de la Serna E, Butjosa A, Contreras F, Sarró S, Penadés R, Sánchez-Torres AM, Cuesta M, Bernardo M; PEPsGroup. Amoretti S, et al. Acta Psychiatr Scand. 2018 Nov;138(5):441-455. doi: 10.1111/acps.12949. Epub 2018 Aug 14. Acta Psychiatr Scand. 2018. PMID: 30105820
Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis.
González-Ortega I, González-Pinto A, Alberich S, Echeburúa E, Bernardo M, Cabrera B, Amoretti S, Lobo A, Arango C, Corripio I, Vieta E, de la Serna E, Rodriguez-Jimenez R, Segarra R, López-Ilundain JM, Sánchez-Torres AM, Cuesta MJ; PEPs Group:; Zorrilla I, López P, Bioque M, Mezquida G, Barcones F, De-la-Cámara C, Parellada M, Espliego A, Alonso-Solís A, Grasa EM, Varo C, Montejo L, Castro-Fornieles J, Baeza I, Dompablo M, Torio I, Zabala A, Eguiluz JI, Moreno-Izco L, Sanjuan J, Guirado R, Cáceres I, Garnier P, Contreras F, Bobes J, Al-Halabí S, Usall J, Butjosa A, Sarró S, Landin-Romero R, Ibáñez A, Selva G. González-Ortega I, et al. Among authors: segarra r. Psychol Med. 2020 Dec;50(16):2702-2710. doi: 10.1017/S0033291719002794. Epub 2019 Oct 22. Psychol Med. 2020. PMID: 31637990
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study.
García-Rizo C, Bioque M, Mezquida G, Amoretti S, Cuesta MJ, Díaz-Caneja CM, Mas S, Lobo A, González-Pinto A, Fraguas D, Corripio I, Vieta E, Baeza I, Bergé D, Fernandez-Egea E, Garriga M, Bernardo M; PEPs GROUP. García-Rizo C, et al. Schizophr Res. 2020 Apr;218:292-294. doi: 10.1016/j.schres.2019.12.030. Epub 2020 Jan 27. Schizophr Res. 2020. PMID: 32001078 No abstract available.
Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms.
Recio-Barbero M, Segarra R, Zabala A, González-Fraile E, González-Pinto A, Ballesteros J. Recio-Barbero M, et al. Among authors: segarra r. Front Psychiatry. 2021 Apr 6;12:631589. doi: 10.3389/fpsyt.2021.631589. eCollection 2021. Front Psychiatry. 2021. PMID: 33889097 Free PMC article.
A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients.
Zabala A, Bustillo M, Querejeta I, Alonso M, Mentxaka O, González-Pinto A, Ugarte A, Meana JJ, Gutiérrez M, Segarra R. Zabala A, et al. Among authors: segarra r. J Clin Psychopharmacol. 2017 Oct;37(5):569-577. doi: 10.1097/JCP.0000000000000770. J Clin Psychopharmacol. 2017. PMID: 28796022 Free PMC article. Clinical Trial.
61 results